Integrating c-Met molecular imaging into the optimisation of cancer therapy
Basal-like subtypes of breast cancer (BLBC) account for about 15-20% of all breast cancer, affecting younger women (<50 years old) of predominantly African and Hispanic descent [1] with rapid relapse ([2]. c-Met is overexpressed in various solid tumors, lung, breast, ovary, kidney, colon, thyroid...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
King's College London (University of London)
2016
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.700783 |